Angiogenesis in Cutaneous Lesions of Leprosy: Implications for Treatment
Overview
Authors
Affiliations
Objective: To examine the potential role of angiogenesis in leprosy.
Design: Immunohistochemical analysis of leprosy lesions.
Setting: Department of Dermatology, Venereology, and Leprology, Kasturba Medical College; Division of Dermatology, University of California at Los Angeles; and Departments of Dermatology and Pathology, Emory University.
Patients: Thirty-two cutaneous lesions that represented the spectrum of leprosy were obtained from 32 patients.
Main Outcome Measure: CD31 microvessel counts.
Results: The mean CD31 microvessel count in borderline tuberculoid, midborderline, and lepromatous leprosy lesions was significantly higher than in indeterminate leprosy lesions.
Conclusions: Increased bacterial load is associated with increased angiogenesis. Angiogenesis inhibitors may be of benefit in the treatment of leprosy.
Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination.
Polena H, Boudou F, Tilleul S, Dubois-Colas N, Lecointe C, Rakotosamimanana N Sci Rep. 2016; 6:33162.
PMID: 27616470 PMC: 5018821. DOI: 10.1038/srep33162.
Bhandarkar S, Lanka P, Lanka L, Veledar E, Bonner M, MacKelfresh J Exp Dermatol. 2016; 25(6):479-80.
PMID: 26896643 PMC: 4880505. DOI: 10.1111/exd.12980.
Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms.
Soares C, Rosa P, Trombone A, Fachin L, Ghidella C, Ura S PLoS One. 2013; 8(9):e74651.
PMID: 24040306 PMC: 3765444. DOI: 10.1371/journal.pone.0074651.
Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy.
El-Khalawany M, Shaaban D, Sultan M, Abd Alsalam F Clin Cosmet Investig Dermatol. 2012; 5:1-6.
PMID: 22291474 PMC: 3267406. DOI: 10.2147/CCID.S26200.
Manca C, Peixoto B, Malaga W, Guilhot C, Kaplan G J Interferon Cytokine Res. 2011; 32(1):27-33.
PMID: 21981546 PMC: 3255513. DOI: 10.1089/jir.2011.0044.